Surrogate Modelling of Proton Dose with Monte Carlo Dropout Uncertainty Quantification
Aaron Pim, Tristan Pryer · 2025
Read Surrogate Modelling of Proton Dose with Monte Carlo Dropout Uncertainty Quantification by Aaron Pim, Tristan Pryer (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2509-18155.txt.
Introduction
Aaron Pim and Tristan Pryer build a fast stand-in for proton dose sums in cancer care. Their 2025 paper deals with a clash: exact Monte Carlo dose maths are trusted, but slow. Care plans that must adapt or weigh risk need many dose sums, fast.
Their neural stand-in adds Monte Carlo dropout, which also gives a doubt score per point. Tests move from a one-dim toy case to bone-water setups and a full 3D water case. Doubt splits into model doubt and input doubt, each with its own zone of weight. Speed gains over Monte Carlo were large, with doubt kept in hand.
Catalog record
| CREATOR | Aaron Pim, Tristan Pryer |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 57 KB |
| VERSION | 1.0 |
| LICENSE | http://creativecommons.org/licenses/by/4.0/ |
| RIGHTS | CC BY |
| SOURCE | arXiv |
Source: https://arxiv.org/abs/2509-18155
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Surrogate Modelling of Proton Dose with Monte Carlo Dropout Uncertainty Quantification Aaron Pim, Tristan Pryer Abstract . Accurate proton dose calculation with Monte Carlo (MC) remains computationally demanding in workflows that require repeated evaluations, such as robust optimisation, adaptive replanning and probabilistic inference. We construct a neural surrogate that incorporates Monte Carlo dropout to provide fast, differentiable dose predictions together with voxelwise predictive uncertainty. The method is validated in a staged series of experiments, a one-dimensional analytic benchmark establishes accuracy, convergence and variance decomposition; two-dimensional bone-water phantoms generated with TOPAS/Geant4 demonstrate behaviour under domain heterogeneity and beam uncertainty and a three-dimensional water phantom confirms scalability to volumetric dose prediction. Across settings we separate epistemic (model) from parametric (input) contributions, showing that epistemic variance inflates under distribution shift while parametric variance dominates at material boundaries. The approach achieves orders-of-magnitude speedup over MC while retaining uncertainty information and is intended for integration into robust planning, adaptive workflows and uncertainty-aware optimisation in proton therapy. 1. Introduction Proton beams deposit most of their energy near the end of range, producing a distal Bragg peak; small changes in tissue composition or density shift this peak and alter dose to targets and organs at risk, so accurate dose calculation is central to planning [ LC11 ] . Deterministic formulations, based on the continuous slowing down approximation or transport equations, capture average behaviour and admit analytic approximations, but they neglect statistical fluctuations [ BLP23 , AHP25 ] . Stochastic formulations, by contrast, describe individual particle paths, accounting for deterministic energy loss from inelastic interactions and random angular deflections from Coulomb scatter, with additional variability introduced by range straggling [ Cro+24 , CP25 , KPP25 ] . Analytic models of both types provide reduced-order descriptions of dose, while numerical approaches range from PDE solvers and pencil-beam algorithms to Monte Carlo and SDE-based simulations [ Ash+25 , NZ15 ] . Monte Carlo (MC) transport remains the reference standard for accuracy but is computationally demanding even when GPU implementations and clinical verifiers are used [ Gia+15 , Zho+24 ] . To reduce wall time while retaining MC fidelity, recent work trains deep surrogates to predict LET and dose with millisecond–second runtimes, e.g. LET calculators and 3-D dose/LETD predictors trained on MC or hybrid data [ Tan+24 , Pir+22 , PP22 , Sta+24 ] and extends to heavy-ion therapy for online adaptation and rapid QA [ He+25a , He+25 ] . Complementary denoisers map low-particle MC to high-quality dose, shrinking simulation budgets [ Zha+23 ] , and fast conversions lift pencil-beam solutions to MC-quality dose in seconds for clinical use [ Wu+21 ] . These accelerations address speed, not trust. Deterministic predictors provide point estimates only; uncertainty quantification (UQ) is needed to audit reliability, enable robust optimisation [ GP25 ] , dose delivery inference [ Cox+24 ] and guide data acquisition [ Wil+25 , Stå+20 ] . A practical route is Monte Carlo dropout (MC-dropout). Dropout was introduced as a regulariser that randomly masks activations during training to reduce co-adaptation [ Sri+14 ] and later reinterpreted as approximate Bayesian inference, so repeated stochastic test-time passes yield predictive means and variances with minimal code changes [ GG16 ] . Variants improve calibration and sample efficiency [ Has+23 ] and applications in medical imaging show that uncertainty highlights failure modes and supports downstream decisions [ Sah+24 , Kla+23 ] . These ingredients motivate an uncertainty-aware surrogate pipeline that scales from one-dimensional depth-dose to full three-dimensional dose. Clinically, the appeal of protons is precisely the steep distal fall-off around the Bragg peak. That strength is also a vulnerability, millimetric errors in water-equivalent path length, unmodelled heterogeneity, or small setup shifts can displace the high-dose region relative to target and organs at risk. In practice this means that accuracy at the distal edge is not only a numerical goal but a planning requirement, since misplacement of the peak risks target under-dosage or excess dose to critical structures. This sensitivity concentrates the need for trustworthy predictions where gradients are largest and where tissue changes most strongly affect range [ LC11 ] . Despite advances in GPU implementations and clinically validated verifiers [ Gia+15 , Zho+24 ] , full MC remains costly for workflows that require many evaluations. Modern planning iterates dose engines thousands of times, robust optimisation evaluates scenarios across range and setup perturbations, adaptive workflows revisit dose after anatomical change and probabilistic inversion or Bayesian calibration loops demand repeated forward solves. Denoisers [ Zha+23 ] and fast conversions from analytic models [ Wu+21 ] mitigate per-evaluation cost, yet the cumulative budget for high-fidelity MC still restricts the breadth of scenario sets and the use of sampling-based UQ within tight clinical time frames. Fast surrogates promise a complementary path. By learning the map from beam and medium parameters to dose, a differentiable emulator can be embedded in inner optimisation loops, enable sensitivity analysis with automatic differentiation and support sampling-based analyses at interactive speeds. This aligns with emerging applications in online adaptation, rapid QA and heavy-ion settings [ Tan+24 , Pir+22 , PP22 , Sta+24 , He+25a , He+25 ] . However, point predictions alone are insufficient for safe decision making. Robust planning, data-efficient acquisition and model auditing all require uncertainty estimates that are well calibrated and that respond sensibly to distribution shift [ Wil+25 , Stå+20 ] . This creates an unmet need for uncertainty-aware fast dose predictors, these models approach MC fidelity in nominal cases, expose voxelwise uncertainty that inflates at distal fall-off and material interfaces, and remain simple enough to deploy within existing planning stacks. MC-dropout offers a pragmatic solution [ GG16 , Sri+14 ] . It preserves the usual training and inference toolchain, yields test-time ensembles with minimal code changes and retains compatibility with automatic differentiation for optimisation. Controlled variants can improve calibration [ Has+23 ] and prior literature in medical imaging suggests that the resulting uncertainty maps can flag likely failure modes and guide downstream choices [ Sah+24 , Kla+23 ] . In this work we adopt MC-dropout to construct a surrogate pipeline that runs from 1-D depth-dose to 3-D dose, quantifies both model and input variability and incorporates simple post-hoc calibration so nominal and empirical coverages agree. 1.1. Contribution of the work We construct a neural surrogate for proton dose that exposes calibrated predictive uncertainty through MC-dropout while retaining automatic differentiation for optimisation and inference. Our approach proceeds in stages of increasing dimensionality and complexity. We begin with a one-dimensional analytic benchmark of depth-dose profiles using the model from [ Ash+25 ] . This controlled setting allows us to test the surrogate against a model with closed-form behaviour, establish the accuracy of mean predictions, and examine sharpness and empirical coverage of credible intervals. Mathematically, the 1-D case provides a clean setting for variance decomposition and convergence studies (in training samples and dropout passes), while clinically it corresponds to the core range-dose trade-off at the Bragg peak that underlies proton therapy [ LC11 ] . We then extend to two-dimensional log-projection maps in a controlled bone-water phantom. Here, the surrogate is trained on MC-generated data from TOPAS/Geant4, with uncertainty in bone position and thickness capturing heterogeneity effects. This stage demonstrates that the surrogate generalises from analytic inputs to realistic voxelised MC data,